<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1BD4A556-B16E-4335-AE9D-9DD36A9FEF33"><gtr:id>1BD4A556-B16E-4335-AE9D-9DD36A9FEF33</gtr:id><gtr:name>University Hospitals of Morecambe Bay NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/38DA8475-FCB8-48CD-A66D-2226087E51CE"><gtr:id>38DA8475-FCB8-48CD-A66D-2226087E51CE</gtr:id><gtr:name>Lancashire Teaching Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/44160F04-5CBF-4E8E-A6C6-C0EF61A5865C"><gtr:id>44160F04-5CBF-4E8E-A6C6-C0EF61A5865C</gtr:id><gtr:name>Lancaster University</gtr:name><gtr:department>Division of Biomedical and Life Sciences</gtr:department><gtr:address><gtr:line1>University House</gtr:line1><gtr:line4>Lancaster</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>LA1 4YW</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/44160F04-5CBF-4E8E-A6C6-C0EF61A5865C"><gtr:id>44160F04-5CBF-4E8E-A6C6-C0EF61A5865C</gtr:id><gtr:name>Lancaster University</gtr:name><gtr:address><gtr:line1>University House</gtr:line1><gtr:line4>Lancaster</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>LA1 4YW</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1BD4A556-B16E-4335-AE9D-9DD36A9FEF33"><gtr:id>1BD4A556-B16E-4335-AE9D-9DD36A9FEF33</gtr:id><gtr:name>University Hospitals of Morecambe Bay NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/38DA8475-FCB8-48CD-A66D-2226087E51CE"><gtr:id>38DA8475-FCB8-48CD-A66D-2226087E51CE</gtr:id><gtr:name>Lancashire Teaching Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/727E7F43-08C7-4030-83D1-B4009B65EE27"><gtr:id>727E7F43-08C7-4030-83D1-B4009B65EE27</gtr:id><gtr:firstName>Rachael</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Rigby</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100211"><gtr:id>F77D2265-4CB1-4ED0-B10E-BCE4DFCC2C99</gtr:id><gtr:title>Suppressor of cytokine signaling 3 is a key regulator of intestinal epithelial homeostasis.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100211</gtr:grantReference><gtr:abstractText>A single layer of epithelial cells line the entire intestinal tract and provide a first line of defence against infectious agents within the gut contents. Inflammatory bowel disease (IBD), comprising Crohn?s disease and Ulcerative colitis, involves inflammation and destruction of this intestinal epithelial lining. Studies estimate that as many as 1 in 100 people in the UK will develop IBD, of varying severity, during their lifetime. Recent evidence suggests that the rate at which the lining of our intestine is repaired is dependent on interactions with bacteria residing within our gut. Potential reasons why IBD is on the increase in developed countries include changes in diet and in the microbes residing in our gut. Epithelial replenishment needs to be efficient enough to repair the intestine lining without being excessive, as overgrowth can lead to cancer. Short-term increases in epithelial overgrowth are sometimes required to expel intestinal pathogens such as rotavirus and whipworms, as without this controlled growth, chronic infection and illness will occur. Evidence implicates that the balance of epithelial cell growth is achieved in part through the actions of a protein termed suppressor of cytokine signalling 3 (SOCS3), expressed within epithelial cells. Previous work demonstrated that SOCS3 is an effective intestinal tumour suppressor, but what we do not know is whether SOCS3 inhibits normal as well as cancerous growth. The experiments proposed are designed to test the ability of SOCS3 to mediate the balance between excessive epithelial cell growth and allowing necessary division for repair and protection against pathogens. It is important that we identify factors which govern the growth and health of the intestine in response to our changing diets and intestinal microbes, if we are to prevent the increasing burden of gastrointestinal diseases.</gtr:abstractText><gtr:technicalSummary>In a healthy human adult the single layer of intestinal epithelial cells (IEC) lining the gastro-intestinal tract replenishes itself approx. every 4-5 days. This high rate of proliferation is second only to haemopoetic cell lineages, therefore IEC represent a population of cells requiring careful regulation of cell division. Recent studies have highlighted the role of microbial-sensing Toll-like receptors (TLR) in maintaining IEC homeostasis. Under some circumstances, such as following insult to the intestine during pathogenic viral and helminth infection, hyper-proliferation of the epithelium is required to expel the invading pathogen. However, sustained excessive proliferation of IEC can lead to dysplasia and cancer. Identifying factors that govern the balance between intestinal replenishment and resistance to infection, without predisposing to dysplasia and cancer, is key to understanding how intestinal homeostasis is maintained. Evidence implicates suppressor of cytokine signalling 3 (SOCS3) as a modulator of cellular proliferation. SOCS3 acts as a negative feedback inhibitor to regulate TLR-induced inflammatory signalling pathways that promote proliferation. In 2007, the P.I. published studies showing that SOCS3 inhibited growth of colonic tumours in a model of inflammation-induced cancer. The experiments outlined in this proposal are designed to investigate the role of SOCS3 in balancing the magnitude and/or duration of ?inflammatory? signalling, controlling normal IEC homeostasis, using both in vitro and in vivo models. Understanding the mechanisms that control IEC homeostasis are key to future therapies to modulate the rate of epithelial replenishment, repair and renewal important in many diseases such as intestinal pathogen infection, inflammatory bowel disease and colon cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2015-10-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>342683</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Life Sciences</gtr:department><gtr:description>Trichuris project</gtr:description><gtr:id>EB418CF2-555B-4B05-85A1-27E9A2BF3450</gtr:id><gtr:impact>Abstract presented at Experimental Biology meeting 2011. One manuscript published (Nov 2014) and another in preparation.</gtr:impact><gtr:outcomeId>pk3UYCFPuCP-1</gtr:outcomeId><gtr:partnerContribution>Advice and guidance regarding protocols, provision of reagents, use of facilities</gtr:partnerContribution><gtr:piContribution>Scientific discussion, user of Manchester facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Improving outcome of stoma reversal surgery</gtr:description><gtr:id>1A43EA06-259B-49D9-A8BB-C56907A82BCF</gtr:id><gtr:impact>Funding acquired from Bowel cancer research. Preliminary data has been presented both in oral and poster format, manuscript in preparation.</gtr:impact><gtr:outcomeId>HHnqzrneuU3-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input and methodological guidance and data analysis.</gtr:partnerContribution><gtr:piContribution>Conception of the study plan, Gathering of preliminary data, writing grant proposal, collaboration with NHS partners</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lancashire Teaching Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Surgery Sevices</gtr:department><gtr:description>Improving outcome of stoma reveral surgery</gtr:description><gtr:id>50110A2C-3641-4800-B6BB-C8D426EC8643</gtr:id><gtr:impact>Successful bid for funds from Bowel Cancer Research. Poster and oral presentation, manuscript in preparation.</gtr:impact><gtr:outcomeId>tsgQC4rfMto-1</gtr:outcomeId><gtr:partnerContribution>Conception of research study, provision of tissue samples</gtr:partnerContribution><gtr:piContribution>Conception of research study, preparation of bid for research funding, preparation of NHS ethics application, provision of preliminary data</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals of Morecambe Bay NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gastroenterology</gtr:department><gtr:description>Intestinal Health</gtr:description><gtr:id>76AD8823-DF4B-4858-A2C9-79A48801B28B</gtr:id><gtr:impact>No outcomes yet</gtr:impact><gtr:outcomeId>fTsQSw8Kw4y-1</gtr:outcomeId><gtr:partnerContribution>Provision of samples and intellectual input</gtr:partnerContribution><gtr:piContribution>Conception of research study plan, provision of preliminary data, intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Nuffield student summer placement</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2E8CDDBB-0670-4AC5-A9E4-EC2543B416DA</gtr:id><gtr:impact>Students from local sixth form colleges spent 4 weeks in the laboratory working on their own scientific project. Both students applied to medical school shortly after their placements.

Student in 2009 is now studying medicine. Good feedback from students and Nuffield foundation.</gtr:impact><gtr:outcomeId>RyteXqh33JB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tissue culture demonstation on applicant visit days (prospective parents and their parents)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4D460F2E-C356-4AD5-9589-E52D996580F1</gtr:id><gtr:impact>Received good feedback from a parent of a prospective student in a follow up email.</gtr:impact><gtr:outcomeId>58c26ee86fc813.40634230</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'A Career in Science' School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>707373ED-D060-451C-8C64-F77AAF238846</gtr:id><gtr:impact>'A Career in science' talk at Lancaster Grammar School</gtr:impact><gtr:outcomeId>58c26e17bf6000.36164725</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit (Lancaster Grammar)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A6AB27EA-046C-4951-A469-53E97CB88987</gtr:id><gtr:impact>20 sixth-form 'med soc' pupils attended the research/career talk. These pupils intend to apply for medical school or a biomedical-related degree scheme within the next 2 years.

Recieved good feedback and sparked discussion about scientific careers. School also requested additional visits from other members of staff within the Faculty.</gtr:impact><gtr:outcomeId>XQaufRtNwGh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>47272</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Improving outcome of stoma reversal surgery</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Bowel &amp; Cancer Research</gtr:fundingOrg><gtr:id>7FF15538-F843-48BD-B94D-6714FFEFB1BF</gtr:id><gtr:outcomeId>nYqTdibr4uV</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>535307D9-4FC4-490A-B197-FA902ADF7BC9</gtr:id><gtr:title>Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation.</gtr:title><gtr:parentPublicationTitle>Immunity, inflammation and disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce5e8014c10cd5b84c56b9769c66d6aa"><gtr:id>ce5e8014c10cd5b84c56b9769c66d6aa</gtr:id><gtr:otherNames>Shaw EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-4527</gtr:issn><gtr:outcomeId>5a995662511c39.67851406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF562339-303F-49EF-9655-426C767EF58D</gtr:id><gtr:title>Intestinal epithelial suppressor of cytokine signaling 3 enhances microbial-induced inflammatory tumor necrosis factor-a, contributing to epithelial barrier dysfunction.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/834370c7ac9b38eab66a633ee9b195a2"><gtr:id>834370c7ac9b38eab66a633ee9b195a2</gtr:id><gtr:otherNames>Thagia I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>doi_55f985985af63412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CA31A78-B6A9-4A90-8A6C-D4F8D89BF65F</gtr:id><gtr:title>Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cf450b47c34acbd843e44f37b84dc3b"><gtr:id>7cf450b47c34acbd843e44f37b84dc3b</gtr:id><gtr:otherNames>Koay LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>pm_540e17ae17a82a9a7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100211</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>